Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study

By Chakravatri A.   Zehr E.M.   Zietman A.L.   Shipley W.U.   Goggins W.B.   Finkelstein D.M.   Young R.H.   Chang E.L.   Wu C.-L.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 635-638

Elsevier

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

By Partin A.W.   Catalona W.J.   Finlay J.A.   Darte C.   Tindall D.J.   Young C.Y.-F.   Klee G.G.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 839-845

Elsevier

Access to resources Recommend Favorite

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer - relationship of doubling time to clinical outcome

By Mackey T.J.   Borkowski A.   Amin P.   Jacobs S.C.   Kyprianou N.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1085-1090

Elsevier

Access to resources Recommend Favorite